MedTrace Logo

Study of High Sensitive Troponin-I Level in End-stage Renal Disease Patients Receiving Hemodialysis

NCT02572466 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 207

Last updated 2016-01-29

No results posted yet for this study

Summary

This study objective is to compare the high sensitive troponin-I level in end-stage renal disease patients received hemodialysis without acute cardiovascular event with healthy population. The investigators also determine the effect of hemodialysis on troponin I level as the secondary objective.

Conditions

  • End-stage Renal Disease

Interventions

OTHER

Hemodialysis

ESRD group received long-term hemodialysis

Sponsors & Collaborators

  • Chulalongkorn University

    lead OTHER

Principal Investigators

  • Khajohn Tiranathanagul, MD · Chulalongkorn University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-02-28
Primary Completion
2015-11-30
Completion
2015-11-30

Countries

  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02572466 on ClinicalTrials.gov